Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
ROBO Global Robotics & Automation Index ETF
ROBO
$1.96B
| $54.6M | 0.01% |
1,256,503
+71,842
| +6% | +$2.86M |
|
802
Nuveen Quality Municipal Income Fund
NAD
$2.74B
| $54.6M | 0.01% |
3,895,371
-744,475
| -16% | -$10.2M |
|
|
IPHI
803
DELISTED
INPHI CORPORATION
IPHI
| $54.3M | 0.01% |
462,137
-339,296
| -42% | -$35.7M |
|
804
Insulet
PODD
$11.5B
| $54.2M | 0.01% |
279,104
-9,276
| -3% | -$1.77M |
|
805
Cognex
CGNX
$10.9B
| $54.2M | 0.01% |
907,554
+714,725
| +371% | +$38.8M |
|
806
Appian
APPN
$1.98B
| $54M | 0.01% |
1,053,585
+449,393
| +74% | +$21.9M |
|
807
Vanguard Global ex-US Real Estate ETF
VNQI
$3.52B
| $53.9M | 0.01% |
1,156,213
-155,225
| -12% | -$7.02M |
|
|
PSXP
808
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $53.7M | 0.01% |
1,489,012
+681,296
| +84% | +$28.3M |
|
809
Alcon
ALC
$33.6B
| $53.6M | 0.01% |
935,797
-53,115
| -5% | -$3.01M |
|
810
ALPS Sector Dividend Dogs ETF
SDOG
$1.4B
| $53.6M | 0.01% |
1,473,620
-330,043
| -18% | -$11.6M |
|
811
Lincoln National
LNC
$8.72B
| $53.5M | 0.01% |
1,455,045
+173,429
| +14% | +$6.1M |
|
812
Cadence Design Systems
CDNS
$93.6B
| $53.5M | 0.01% |
557,471
+275,898
| +98% | +$23.1M |
|
813
Cardlytics
CDLX
$21.7M
| $53.4M | 0.01% |
76,318
+45,470
| +147% | +$26.3M |
|
814
Lumen
LUMN
$6.57B
| $53.3M | 0.01% |
5,311,278
-1,234,819
| -19% | -$12.4M |
|
815
Xylem
XYL
$27.3B
| $53M | 0.01% |
815,915
+195,188
| +31% | +$12.9M |
|
816
Schneider National
SNDR
$6.26B
| $52.9M | 0.01% |
2,145,586
+124,593
| +6% | +$2.74M |
|
817
Capri Holdings
CPRI
$1.83B
| $52.9M | 0.01% |
3,385,426
+456,001
| +16% | +$6.75M |
|
818
CarMax
KMX
$8.13B
| $52.8M | 0.01% |
589,118
-130,216
| -18% | -$10.2M |
|
819
ProShares Short Russell2000
RWM
$132M
| $52.4M | 0.01% |
1,447,029
+484,883
| +50% | +$19.8M |
|
820
Ally Financial
ALLY
$13.2B
| $52.2M | 0.01% |
2,630,819
+1,788,670
| +212% | +$30.4M |
|
821
Beyond Meat
BYND
$292M
| $52M | 0.01% |
388,011
+67,097
| +21% | +$7.94M |
|
822
Dover
DOV
$27.6B
| $51.8M | 0.01% |
536,930
-33,566
| -6% | -$3.1M |
|
823
Sprott Physical Gold
PHYS
$14.6B
| $51.8M | 0.01% |
3,620,817
+935,960
| +35% | +$12.9M |
|
824
Skyworks Solutions
SWKS
$9.37B
| $51.4M | 0.01% |
401,712
-44,500
| -10% | -$4.93M |
|
825
iShares Morningstar Mid-Cap ETF
IMCB
$1.65B
| $51.3M | 0.01% |
1,112,540
-106,688
| -9% | -$4.64M |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.